ArticleNPJ digital medicine2026
StructSAM: structure-aware prompt adaptation for robust lung cancer lesion segmentation in CT.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate delineation of lung lesions in computed tomography (CT) scans is critical for diagnosis, staging, and treatment planning, yet remains a challenging task. While foundation models like the Segment Anything Model (SAM) excel in natural images, they often falter in medical imaging due to low contrast, ambiguous boundaries, and a lack of 3D context. To address these limitations, we propose StructSAM, a structure-aware prompt adaptation framework designed for robust volumetric segmentation, with a primary focus on lung cancer. StructSAM injects anatomical priors into the prompt pathway, employs a 3D inter-slice aggregator for volumetric consistency, and leverages PEFT for scalability. Experiments on the LIDC-IDRI dataset demonstrate that StructSAM achieves state-of-the-art accuracy on lung nodule segmentation, outperforming both classical architectures and SAM-based adaptations. Crucially, extended cross-organ evaluations on KiTS19 and MSD Pancreas datasets reveal that StructSAM effectively generalizes to other anatomical structures, highlighting its robustness to domain shifts. These findings suggest that embedding structural priors into foundation models is a promising strategy toward generic, clinically reliable, and efficient medical image segmentation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.